膀胱镜检查
膀胱癌
生物标志物
医学
泌尿系统
金标准(测试)
生物标志物发现
泌尿科
疾病
尿路上皮癌
癌症
肿瘤科
内科学
蛋白质组学
生物
基因
生物化学
作者
Jamie D'Costa,James Goldsmith,Jayne S. Wilson,Richard T. Bryan,Douglas G. Ward
出处
期刊:Bladder cancer
[IOS Press]
日期:2016-07-27
卷期号:2 (3): 301-317
被引量:80
摘要
For over 80 years, cystoscopy has remained the gold-standard for detecting tumours of the urinary bladder. Since bladder tumours have a tendency to recur and progress, many patients are subjected to repeated cystoscopies during long-term surveillance, with the procedure being both unpleasant for the patient and expensive for healthcare providers. The identification and validation of bladder tumour specific molecular markers in urine could enable tumour detection and reduce reliance on cystoscopy, and numerous classes of biomarkers have been studied. Proteins represent the most intensively studied class of biomolecule in this setting. As an aid to researchers searching for better urinary biomarkers, we report a comprehensive systematic review of the literature and a searchable database of proteins that have been investigated to date. Our objective was to classify these proteins as: 1) those with robustly characterised sensitivity and specificity for bladder cancer detection; 2) those that show potential but further investigation is required; 3) those unlikely to warrant further investigation; and 4) those investigated as prognostic markers. This work should help to prioritise certain biomarkers for rigorous validation, whilst preventing wasted effort on proteins that have shown no association whatsoever with the disease, or only modest biomarker performance despite large-scale efforts at validation.
科研通智能强力驱动
Strongly Powered by AbleSci AI